FM, E., J, B., HY, E., MAE, A., A, O., L, E., . . . SA, S. (2026). CAR-T Cell Therapy Versus Salvage Chemotherapy in Relapsed/Refractory DLBCL: A Systematic Review and Meta-Analysis Integrating Radiologic, Laboratory, and Histopathologic Correlates. La Clinica terapeutica, 177(4), 887. https://doi.org/10.7417/CT.2026.2084
Chicago Style (17th ed.) CitationFM, Elsayed, et al. "CAR-T Cell Therapy Versus Salvage Chemotherapy in Relapsed/Refractory DLBCL: A Systematic Review and Meta-Analysis Integrating Radiologic, Laboratory, and Histopathologic Correlates." La Clinica Terapeutica 177, no. 4 (2026): 887. https://doi.org/10.7417/CT.2026.2084.
MLA (9th ed.) CitationFM, Elsayed, et al. "CAR-T Cell Therapy Versus Salvage Chemotherapy in Relapsed/Refractory DLBCL: A Systematic Review and Meta-Analysis Integrating Radiologic, Laboratory, and Histopathologic Correlates." La Clinica Terapeutica, vol. 177, no. 4, 2026, p. 887, https://doi.org/10.7417/CT.2026.2084.